Status:
COMPLETED
Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
Lead Sponsor:
Pfizer
Conditions:
Hypertension
Eligibility:
All Genders
18-65 years
Brief Summary
This is a Post-Marketing Surveillance study evaluating the Efficacy, Tolerability and Safety of Olmesartan medoxomil 20 mg in combination with 12.5 MG of hydrochlorothiazide in subjects with mild to m...
Detailed Description
Non Probability Sampling
Eligibility Criteria
Inclusion
- Male and Female patients 18 to 65 y/old
- Patient previously taking low-dose medoxomil or any other ARB alone with uncontrolled BP
- Patient with uncontrolled mild to moderate hypertension (SBP\>= 140 and \<=179 mmHg OR DBP of \>=90 and \<=109 mmHg)
Exclusion
- Pregnant of Lactating women
- History of secondary hypertension
Key Trial Info
Start Date :
July 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
1723 Patients enrolled
Trial Details
Trial ID
NCT00796159
Start Date
July 1 2007
End Date
December 1 2008
Last Update
December 23 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.